AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 291 min read$ISRG

Brosius Mark sold $30K of ISRG

Brosius Mark (EVP & Chief Mfg and Supply Cha) sold 84 shares of INTUITIVE SURGICAL INC (ISRG) at an average of $356.60 ($344.00–$365.58) across 3 trades over 2026-07-27 to 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brosius Mark
Published Jul 29, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ISRG
Neutral
high confidence
Mentioned
$ISRG
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ISRGNeutralLow
01

Why it matters

The newest fact is the specific open-market sale by an officer under a pre-arranged 10b5-1 plan; it does not provide new operational or financial information about ISRG.

02

Market read

Traders may note incremental insider selling, but the planned nature and modest dollar value suggest limited decision impact.

03

What to watch

The sale size is small relative to typical ISRG trading activity, and the disclosure does not include any new company-specific developments.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-29 after-hours; reflects sales executed 2026-07-27 to 2026-07-29.

Background

The article is an SEC Form 4 insider transaction disclosure for Intuitive Surgical (ISRG).

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Form 4 shows ISRG EVP Mark Brosius sold $29,954 of shares in open-market trades under a pre-arranged 10b5-1 plan (84 shares).

Expected impact

Likely minimal near-term impact; any effect is typically absorbed as routine 10b5-1 selling.

Evidence & confidence

The filing is an insider open-market sale, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific news (earnings, guidance, deal, or regulatory action).

Market effects

Sector

No direct read-through to medical device sector fundamentals from a small, planned insider sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even planned 10b5-1 sales can coincide with internal views on valuation or liquidity needs, so some traders may still treat it as mild bearish sentiment.

Key entities

  • issuer
    ISRG

    Intuitive Surgical, the company whose insider transaction is disclosed.

  • insider
    Brosius Mark

    EVP and Chief Mfg and Supply Chain officer who sold shares.

  • trading mechanism
    10b5-1 plan

    Pre-arranged plan indicating the trades were scheduled in advance.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ISRG insider trading history →

Related articles

SEP 30
$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

massdevice.com2 min
SEP 29
$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

mddionline.com3 min
SEP 15
$ISRGHighAI 8/10

Intuitive receives CE mark for transvaginal use of da Vinci SP system

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci SP system for transvaginal gynecological procedures in Europe, expanding its use in women's health. The system, already approved for other surgeries, allows single-incision operations, potentially improving recovery and outcomes. It is also approved in the US, Japan, and Korea.

yahoo.com2 min
SEP 14
$ISRGHigh

Intuitive announces expanded indication for da Vinci SP in Europe

Intuitive (ISRG) received CE mark approval for transvaginal gynecologic procedures using the da Vinci SP system in Europe, expanding its applications. The approval allows for less invasive options and potentially better recovery experiences. The system is already approved in the US, Japan, and Korea for various procedures.

prnewswire.com2 min